| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 26, 2026 4:00 P.M. |
| Form: | F-1 | ||||||
| |||||||
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
424B4 - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
EFFECT - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
Wuxi, China, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) (the "Company") today announced the closing of a best-efforts follow-on public offering of 21,875,000 units (each a "Unit") at an offering price of US$0.112 per Unit. Each Unit consists of one Class A ordinary share of the Company, par value US$0.00002 per share (each, a "Class A Ordinary Share") and one warrant to purchase one Class A Ordinary Share, or up to nine Class A Ordinary Shares pursuant to the alternative cashless exercise mechanism described therein (each, a "Warrant"). Each Warrant has an exercise price of US$0.112 per Class A Ordinary Share and is exercisable beginning on th
Wuxi, China, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) (the "Company") today announced the pricing of a best-efforts follow-on public offering of 21,875,000 units (each a "Unit") at an offering price of US$0.112 per Unit. Each Unit consists of one Class A ordinary share of the Company, par value US$0.00002 per share (each, a "Class A Ordinary Share") and one warrant to purchase one Class A Ordinary Share (or up to nine Class A Ordinary Shares pursuant to the zero exercise price option) (each, a "Warrant"). Each Warrant will have an exercise price of US$0.112 per Class A Ordinary Share and will be exercisable beginning on the issuance date a